To describe a clinical relevance of SPI1, PRIC285 and S1PR4 genes, we investigated their promoter methylation status and expression levels in TCGA public genome database (http://cancergenome.nih.gov/) of 29 normal and 230 gastric tumors, which were divided into four subtypes by molecular classification [19]. This evidence concerns the gene SPI1 and gastric neoplasm.